{
  "docId": "019de075-d8f1-727b-b893-5e9d6af9a579",
  "docSlug": "880c8a38f766d3eb6660c74e922f5744",
  "documentTitle": "MindMed | Investor Presentation Deck | 32 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 32,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 10,
  "notes": "The slide presents clinical trial data (STAI-G scores) over 24 weeks, highlighting significant symptom reduction and safety profile.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-d8f1-727b-b893-5e9d6af9a579/13",
  "deckHref": "/decks/019de075-d8f1-727b-b893-5e9d6af9a579",
  "deckJsonHref": "/decks/019de075-d8f1-727b-b893-5e9d6af9a579.json",
  "deckAnchorHref": "/decks/019de075-d8f1-727b-b893-5e9d6af9a579#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.735,
        "w": 0.415,
        "x": 0.535,
        "y": 0.221
      },
      "kind": "chart",
      "text": "Reduction in Anxiety Symptoms (STAI-G)",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99eb57ac-2066-4b4b-9f1a-2138f9c81f90",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.585,
        "w": 0.435,
        "x": 0.058,
        "y": 0.227
      },
      "kind": "list",
      "text": "Rapid, durable and significant anxiolytic effects. Reduction in anxiety and depression symptoms; durable at 16 weeks post-treatment vs. placebo (p<0.007). Clinical response (≥30% reduction) observed in 65% of LSD group vs 9% of placebo group (p<0.003). Positive correlation between acute positive effects or mystical experiences and clinical outcomes. Well-tolerated at 200 µg: 1 serious adverse event (acute transient anxiety and delusions) and no other adverse events attributed to treatment. No instances of suicidal ideation with intent attributed to treatment",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c5b25eaf-5ba8-4dbc-8e2b-1559aa9477fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.215,
        "x": 0.04,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "1. Holze, Gasser et. al 2022. Biological Psychiatry. STAI-G: State-Trait Anxiety Inventory; µg: microgram",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4181da69-05cd-4ee8-b849-ba3387c52be4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.021,
        "w": 0.623,
        "x": 0.058,
        "y": 0.091
      },
      "kind": "title",
      "text": "Results from UHB's LSD-Assist study support MindMed's clinical development of MM-120 for GAD",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d3b96123-da82-48db-847b-406fb699da7d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.042,
        "w": 0.415,
        "x": 0.058,
        "y": 0.035
      },
      "kind": "title",
      "text": "Modern Evidence in Anxiety Disorders",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "470faace-e4a2-44e0-b364-a33f03ee3c27",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "5c88b427-425e-4113-8dd1-e65a2570b444",
      "evidence": "The slide presents a clear and concise message, grabbing the audience's attention with 'Results from UHB's LSD-Assist study support MindMed's clinical development of MM-120 for GAD', and providing evidence of effectiveness.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 13,
      "beatId": "ce8cae4b-4547-4a71-ae4e-e1065f111172",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Traction is shown on pages 13-14 with results from UHB's LSD-Assist study.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}